NanoViricides, Inc. (the “Company”), a nanomedicine company developing anti-viral drugs, reported that its CEO, Eugene Seymour, MD, MPH, has been invited to discuss the current Ebola outbreak and the Company’s progress on a novel experimental Ebola drug on “The Independents”, a show on the Fox Business News Channel (FBN) tonight at 9PM EDT.
Liquidia Technologies today announced that it will highlight the transformative attributes of the company’s PRINT® (Particle Replication In Non-Wetting Templates) technology at the 12th International Nanomedicine and Drug Delivery Symposium (NanoDDS) in Chapel Hill, NC at the Carolina Club from October 6 – 8, 2014. NanoDDS is a key annual event for researchers developing next-generation delivery vehicles that can make diagnostics more sensitive and drugs more effective.
Nanoparticles have the potential to revolutionize the medical industry, but they must possess a few critical properties. First, they need to target a specific region, so that they do not scatter throughout the body. They also require some sort of sensing method, so that doctors and researchers can track the particles. Finally, they need to perform their function at the right moment, ideally in response to a stimulus.
A team of bioengineers, molecular biologists, and clinicians used a novel rare cell-sorter to isolate breast cancer cells from the blood of patients, with the aim of identifying the most effective drugs to treat each individual tumor. Circulating tumor cells (CTCs) were isolated and grown in the laboratory for extensive genetic analysis, which enabled the identification and testing of the most effective cancer-killing drugs for those tumors.
Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven't worked that well.
The life science field has seen numerous detection technologies come and go over the years. Some are shooting stars and others become the golden standard. Photon upconversion is a novel detection technology that has raised much enthusiasm among researchers during recent years.
Case Western Reserve University researchers hope to take a healthy salad up a level by growing a vaccine for an aggressive form of breast cancer in leafy greens.
NanoViricides, Inc. reports that it has shipped FluCide™ to BASi for the start of toxicology studies. NanoViricides has chosen BioAnalytical Systems Inc. Toxicology Services of West Lafayette, Indiana to perform our safety/toxicology studies as needed for an IND submission of the Injectable FluCide drug candidate.
Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering.
We face an urgent global health problem because scientists are not developing new antibiotics as fast as bacteria are developing antibiotic resistance.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.